AeroVironment (AVAV) says it received an order valued at $4,862,674 under a contract with the Norwegian...
Parker-Hannifin (NYSE:PH) reported Q4 EPS of $1.79, missing consensus estimates of $1.80 per share. Revenues for the quarter rose 22.4% year-over-year to $3.41 billion, ahead of consensus estimates of $3.36 billion.
The company sees 2012 EPS of $6.70 to $7.50, vs. consensus estimates of $...
Becton Dickinson (NYSE:BDX) reported Q3 EPS of $1.53, ex-items, ahead of consensus estimates of $1.43 per share. Revenues rose 10% year-over-year to $2.01 billion, topping consensus estimates of $1.99 billion.
The company sees 2011 EPS of $5.65 to $5.70, up from $5.55 to $5.65 per share,...
Cognizant Technology Solutions Corp. (NASDAQ:CTSH) reported Q2 EPS of $0.67, ahead of consensus estimates of $0.66 per share. Revenues rose 34.4% year-over-year to $1.49 billion, topping consensus estimates of $1.46 billion.
The company sees Q3 EPS of $0.70, in line with consensus...
Kulicke & Soffa (NASDAQ:KLIC) reported Q3 EPS of $0.95, ahead of consensus estimates of $0.89 per share. Revenues for the quarter rose 33% year-over-year to $294.4 million, topping consensus estimates of $263.1 million.
The company sees Q4 revenues of $155 to $175 million, vs....
FMC Corp. (NYSE:FMC) reported adjusted Q2 EPS of $1.53, ahead of consensus estimates of $1.51 per share. Revenues for the quarter rose 9% year-over-year to $812.2 million, topping consensus estimates of $811.5 million.
Pierre Brondeau, FMC president, chief executive officer and chairman,...
Polypore (NYSE:PPO) reported Q2 adjusted EPS of $0.63, beating analyst estimates of $0.56 per share. Revenues for the quarter rose 30.8% year-over-year to $196.4 million, better than consensus estimates of $187.15 million.
Robert B. Toth, Chairman, President and Chief Executive Officer,...
Synchronoss Technologies (NASDAQ:SNCR) reported adjusted Q2 EPS of $0.21, ahead of consensus estimates of $0.20 per share. Revenues were $54.8 million, topping consensus estimates of $54.6 million.
Stephen G. Waldis, President and Chief Executive Officer of Synchronoss said, "We are very...
Auxilium Pharmaceuticals (NASDAQ:AUXL) reported a Q2 loss of $0.11 per share, narrower than consensus estimates for a loss of $0.19 per share. Revenues for the quarter rose 30.5% year-over-year to $65.9 million, topping consensus estimates of $64.5 million.
Armando Anido, Chief Executive...
Amgen Inc. (NASDAQ:AMGN) reported Q2 EPS of $1.37, topping analyst estimates of $1.28 per share. Revenues for the quarter rose 4% year-over-year to $4.00 billion topping consensus estimates of $3.78 billion.
The company updated its total revenue guidance for 2011 to be at the upper end of...
Helmerich & Payne (NYSE:HP) reported its Q3 earnings before the market opened today, posting an EPS of $1.01 per diluted share, ahead of analyst estimates for $0.98. Revenue for the quarter also topped expectations for $632.62 million, coming in at just over $644 million.
The company...